Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Zykadia®

ceritinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Zortress®/Certican®

everolimus
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Germany Australia United Kingdom Austria Poland Netherlands Turkey

Zometa®

zoledronic acid
Oncology
Oncology
USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Xolair®

omalizumab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Votrient®

pazopanib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Tyverb®

lapatinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Trileptal®

oxcarbazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Travatan® BAK-Free

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan Z®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

TOBI® Podhaler™

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tafinlar®

dabrafenib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tabrecta™

capmatinib
Oncology
Oncology
USA Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Balance

propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

Simulect®

basiliximab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Seebri Breezhaler®

glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Sandostatin® SC

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin LAR®

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Rydapt®

midostaurin
Oncology
Oncology
Global Product Site USA Product Site

Ritalin®

methylphenidate HCl
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Netherlands Canada Turkey Japan

Ritalin LA®

methylphenidate HCl modified release
Neuroscience
Established Medicines
USA Australia

Promacta®/Revolade®

eltrombopag
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Proleukin®

aldesleukin
Oncology
Oncology
USA Product Site Germany United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey

Piqray®

alpelisib
Oncology
Oncology
USA Product Site USA

Pazeo®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Patanol®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Product Site USA Australia Poland Netherlands Canada Japan

Pataday™

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Onbrez® Breezhaler®

indacaterol
Respiratory
Respiratory
Finland Germany Australia United Kingdom Poland Netherlands Canada Turkey Japan

NETSPOT®

gallium Ga 68 dotatate injection
Advanced Accelerator Applications
USA

Neoral®/Sandimmune®

cyclosporine, USP Modified
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Myfortic®

mycophenolic acid (as mycophenolate sodium)
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Mekinist®

trametinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Mayzent®

siponimod
Neuroscience
Neuroscience
USA Product Site USA

Luxturna®

voretigene neparvovec
Ophthalmology
Ophthalmology
USA Product Site USA

Lutathera®

lutetium Lu 177 dotatate
Advanced Accelerator Applications
USA USA Product Site

Lucentis®

ranibizumab
Ophthalmology
Ophthalmology
Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Lescol® XL

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol®

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lamisil®

terbinafine (terbinafine hydrochloride)
Infectious disease
Established Medicines
USA Germany Australia United Kingdom Poland Canada Turkey

Kymriah™

tisagenlecleucel-T
Oncology
Oncology
Global Product Site USA Product Site

Kisqali®

ribociclib
Oncology
Oncology
Global Product Site USA Product Site

Kesimpta®

ofatumumab
Neuroscience
Neuroscience
USA Product Site USA

Jakavi®

ruxolitinib
Oncology
Oncology
Global Product Site Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Jadenu®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Izba®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Ilevro®/Nevanac®

nepafenac
Ophthalmology
Ophthalmology
Global Product Site USA Germany Canada Australia Austria Poland Netherlands

Ilaris®

canakinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Germany United Kingdom Austria Poland Netherlands Canada Turkey Japan

Gleevec®/Glivec®

imatinib mesylate
Oncology
Oncology
Global Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Gilenya®

fingolimod
Neuroscience
Neuroscience
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Galvus®

vildagliptin
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site Finland Australia United Kingdom Austria Poland Netherlands Turkey

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Femara®

letrozole
Oncology
Oncology
USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey Japan

Farydak®

panobinostat
Oncology
Oncology
Global Product Site USA Germany Austria Poland Netherlands

Extavia®

interferon beta-1b
Neuroscience
Neuroscience
USA Product Site USA Finland Germany United Kingdom Poland Canada

Exjade®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Exforge®

valsartan, amlodipine besylate
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exelon®

rivastigmine
Neuroscience
Established Medicines
USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Eucreas®

vildagliptin, metformin
Cardiovascular, Renal and Metabolism
Respiratory
Global Product Site Finland United Kingdom Austria Poland Netherlands

Entresto®

sacubitril, valsartan
Cardiovascular, Renal and Metabolism
Cardiovascular, Renal and Metabolism
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Egaten®

triclabendazole
Hepatology
Established Medicines
USA

Durezol®

difluprednate
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Duotrav™

travoprost, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Diovan®

valsartan
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey Japan

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Cosentyx®

secukinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Comtan®

entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Netherlands Canada Turkey Japan

Ciprodex®

ciprofloxacin, dexamethasone
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Cibacen®

benazepril hydrochloride
Cardiovascular, Renal and Metabolism
Established Medicines

Beovu®

brolucizumab
Ophthalmology
Ophthalmology
Global USA

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Arzerra®

ofatumumab
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Aimovig®

erenumab
Neuroscience
Neuroscience
USA Product Site USA

Afinitor®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor Disperz®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Adakveo®

crizanlizumab
Oncology
Oncology
Global Product Site US Product Site USA